Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn's disease (CD): protocol of a pilot study.

Charlotte M VerburgtKatherine A DunnAnthony OtleyMelvin B HeymanSofia VerstraeteWithney SunseriFrancisco SylvesterTim de MeijAndre ComeauMorgan LangilleWouter J de JongeMarc A BenningaJohan E Van Limbergen

Published in: BMJ open (2023)

NCT04186247.

Keyphrases

randomized controlled trial
intensive care unit
emergency department
disease activity
ulcerative colitis
rheumatoid arthritis
mesenchymal stem cells
cell therapy
replacement therapy